Lithium Carbonate vs Tofacitinib
Lithium Carbonate vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lithium Carbonate and Tofacitinib.
Mechanism of Action
Lithium Carbonate: Modulates intracellular signaling via inositol and GSK-3 inhibition.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lithium Carbonate β 18-36 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Lithium Carbonate β Li2CO3; Tofacitinib β C16H20N6O.
Molecular Weight: Lithium Carbonate β 73.8910 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Lithium Carbonate β Small molecule; Tofacitinib β Small molecule.